Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2022

Abstract and Keywords

Organised efforts to prevent the spread of infectious diseases through mass vaccination began slowly. By World War I, although successes in saving soldiers’ lives offered encouragement, vaccination practices differed from country to country. In 1945, amid the rapid post-war spread of tuberculosis, preventive vaccination was deemed a necessary ‘technological fix’. During the Cold War period, technical cooperation coexisted with ideological rivalry. Although the Soviet Union and the United States supported vaccination for different reasons, they successfully cooperated on the WHO smallpox eradication programme beginning in 1965. Out of this grew the EPI, and disputes between supporters of ‘vertical’ and ‘horizontal’ approaches emerged. In recent decades new vaccine production has become a major driver of market growth for the pharmaceutical industry. New forms of collaboration between public and private sectors (such as public-private partnerships) have been crafted, whilst the global introduction of new vaccines is supported by the GAVI Alliance. However, at a time of shrinking health care budgets the wisdom of disease eradication targets is contested, and parents everywhere are becoming more critical.

Keywords: disease eradication, global immunisation policy, vertical approach, horizontal approach, EPI, vaccine production, public-private partnership, GAVI Alliance

Stuart Blume

Stuart Blume, University of Amsterdam

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.